State Street Corp lowered its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 65.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,049,674 shares of the company's stock after selling 23,329,237 shares during the period. State Street Corp owned 5.21% of Cardinal Health worth $2,681,052,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in Cardinal Health during the 2nd quarter worth about $6,293,115,000. Wellington Management Group LLP grew its stake in Cardinal Health by 247.5% during the 2nd quarter. Wellington Management Group LLP now owns 14,860,271 shares of the company's stock valued at $3,530,206,000 after purchasing an additional 10,584,119 shares during the last quarter. Bank of America Corp DE purchased a new stake in Cardinal Health during the 2nd quarter valued at about $689,066,000. Legal & General Group Plc acquired a new position in shares of Cardinal Health in the second quarter valued at about $438,870,000. Finally, Pacer Advisors Inc. increased its holdings in shares of Cardinal Health by 14.7% in the first quarter. Pacer Advisors Inc. now owns 1,565,131 shares of the company's stock valued at $330,728,000 after purchasing an additional 200,021 shares during the period. Hedge funds and other institutional investors own 87.17% of the company's stock.
Cardinal Health Stock Performance
NYSE:CAH opened at $272.67 on Friday. The firm's fifty day moving average is $247.94 and its two-hundred day moving average is $226.81. The firm has a market cap of $63.03 billion, a price-to-earnings ratio of 35.27, a PEG ratio of 2.09 and a beta of 0.53. Cardinal Health, Inc. has a one year low of $180.45 and a one year high of $286.29.
Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The company reported $3.26 earnings per share for the quarter, beating analysts' consensus estimates of $2.94 by $0.32. The business had revenue of $67.51 billion during the quarter, compared to analyst estimates of $66.67 billion. Cardinal Health had a negative return on equity of 102.72% and a net margin of 0.71%. The company's revenue was up 5.5% on a year-over-year basis. During the same quarter last year, the business posted $2.55 EPS. As a group, equities research analysts predict that Cardinal Health, Inc. will post 12.96 earnings per share for the current fiscal year.
Cardinal Health Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, January 15th. Investors of record on Monday, January 4th will be issued a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Monday, January 4th. Cardinal Health's dividend payout ratio (DPR) is 26.65%.
Analyst Upgrades and Downgrades
CAH has been the subject of several research analyst reports. Weiss Ratings upgraded Cardinal Health from a "buy (b+)" rating to a "buy (a-)" rating in a research note on Monday, November 9th. Argus upped their target price on Cardinal Health from $264.00 to $309.00 and gave the company a "buy" rating in a research report on Thursday, November 12th. Evercore reiterated an "outperform" rating and issued a $270.00 price target on shares of Cardinal Health in a report on Wednesday, August 12th. Wall Street Zen lowered shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research report on Saturday. Finally, Mizuho set a $290.00 price target on shares of Cardinal Health in a research report on Thursday, November 5th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $290.13.
View Our Latest Stock Analysis on Cardinal Health
Cardinal Health Profile
(
Free Report)
Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. The company's businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations. Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.
Read More
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.